Cargando…

Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity

BACKGROUND: Obesity and type 2 diabetes are drivers of non‐alcoholic fatty liver disease (NAFLD). Glucagon‐like peptide‐1 analogues effectively treat obesity and type 2 diabetes and may offer potential for NAFLD treatment. AIM: To evaluate the effect of the glucagon‐like peptide‐1 analogue, semaglut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Newsome, Philip, Francque, Sven, Harrison, Stephen, Ratziu, Vlad, Van Gaal, Luc, Calanna, Salvatore, Hansen, Morten, Linder, Martin, Sanyal, Arun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Impact of Semaglutide on Liver Enzymes and Inflammation in Type 2 Diabetes and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617813/ https://www.ncbi.nlm.nih.gov/pubmed/31246368 http://dx.doi.org/10.1111/apt.15316

Ejemplares similares

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
por: McPherson, Stuart, et al.
Publicado: (2017)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

The Vildagliptin Experience — 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration
por: Foley, James E, et al.
Publicado: (2017)

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017)

Clinical Safety and Tolerability of Vildagliptin — Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance
por: Mathieu, Chantal, et al.
Publicado: (2017)

Substitution among milk and yogurt products and the risk of incident type 2 diabetes in the EPIC‐NL cohort
por: Stuber, J. M., et al.
Publicado: (2020)

Effects of potato resistant starch intake on insulin sensitivity, related metabolic markers and appetite ratings in men and women at risk for type 2 diabetes: a pilot cross‐over randomised controlled trial
por: Sanders, L. M., et al.
Publicado: (2020)

Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study
por: Wilding, John P H, et al.
Publicado: (2021)

Prevalence of different states of glucose intolerance in Sri Lankan children and adolescents with obesity and its relation to other comorbidities
por: Ciba, Iris, et al.
Publicado: (2020)

Household food insecurity is associated with diabetic ketoacidosis but not severe hypoglycemia or glycemic control in youth and young adults with youth‐onset type 2 diabetes
por: Reid, Lauren A., et al.
Publicado: (2022)

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes
por: Barrientos‐Pérez, Margarita, et al.
Publicado: (2022)

Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide 2.4 MG in Adults With Overweight or Obesity (STEP 1)
por: Wilding, John P H, et al.
Publicado: (2021)

Beta-cell Insufficiency
por: Kalra, Sanjay, et al.
Publicado: (2017)

Rapid progression of type 2 diabetes and related complications in children and young people—A literature review
por: Barrett, Timothy, et al.
Publicado: (2020)

Genetic Risk of Progression to Type 2 Diabetes and Response to Intensive Lifestyle or Metformin in Prediabetic Women With and Without a History of Gestational Diabetes Mellitus
por: Sullivan, Shannon D., et al.
Publicado: (2014)

The Reality of Type 2 Diabetes Prevention
por: Kahn, Richard, et al.
Publicado: (2014)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

A “Spoonful of Sugar” and the Realities of Diabetes Prevention!
por: Cefalu, William T.
Publicado: (2014)

Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
por: Bress, Adam P., et al.
Publicado: (2018)

Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes
por: Lamprea-Montealegre, Julio A., et al.
Publicado: (2018)

Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes?: Health Be Damned! Pour on the Sugar
por: Bray, George A., et al.
Publicado: (2014)

Once-weekly 2.4 mg Semaglutide for Weight Management in Obesity: A Game Changer?
por: Colin, Ides M, et al.
Publicado: (2022)

Glycemic Control and the Weight Benefit of a Daily 7 mg Dose of Oral Semaglutide Versus an Alternate-Day 14 mg Dose of Oral Semaglutide From an Ambulatory Glucose Monitoring Data: A Retrospective Cohort Study From Eastern India
por: RoyChaudhuri, Soumyabrata, et al.
Publicado: (2023)

Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
por: Hanefeld, Markolf, et al.
Publicado: (2013)

Personal Education Programme in Sweden
por: Muoi, Nguyen Thi
Publicado: (1999)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Flow Cytometry”: Guest Editor for the “Flow cytometry” issue: Katherina Psarra
Publicado: (2019)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Improving the Preanalytical Phase in Laboratory Medicine”: Guest Editor for the “Pre-analytical phase” issue: Gabriel Lima-Oliveira
Publicado: (2019)

Request for Nominations for Members for the Committee on Laboratory Management of the Education and Management Division of IFCC
por: Wilkinson, I.
Publicado: (2003)

Past Lives
por: Williams, David L.
Publicado: (2003)

Development of Reference Methods and Reference Materials by the IFCC: An Overview
por: FOREST, JEAN-CLAUDE, et al.
Publicado: (2001)

IFCC Professional Scientific Exchange Programme (PSEP) Report: Plasma Protein Separation Techniques: Ishmael Kasvosve, Zimbabwe: - Report on Scientific Visit
por: Kasvosve, Ishmael
Publicado: (2000)

Clinical Chemistry Question and Answer
por: Apple, Fred S.
Publicado: (1999)

Clinical Chemistry Question and Answer
Publicado: (1999)

IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and Project Presentation
Publicado: (1999)

Visiting lecturer report
por: Siest, G.
Publicado: (2000)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Measurably Better Healthcare”
por: Dow, Ellie, et al.
Publicado: (2020)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Laboratory Aspects of COVID-19 Disease”
Publicado: (2021)

Early Insight Into the Retrospective Data of a Case Series on Type 2 Diabetes Mellitus on Alternate-Day Dosing of Oral Semaglutide: Utopia or Reality?
por: RoyChaudhuri, Soumyabrata, et al.
Publicado: (2023)

Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes
por: Poynard, Thierry, et al.
Publicado: (2021)

Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity
por: John, Linu M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_psds87jtma680981a3n2slk2fd